Disease: tinea pedis

In vitro characterization of Trichophyton rubrum biofilm by combined anti-biofilm enzymes

mycolabadmin

Athlete’s foot and nail fungal infections caused by Trichophyton rubrum are difficult to treat because the fungus forms protective biofilms that resist antifungal medications. This research shows that enzymes like cellulase, protease, and amylase can break down these biofilm barriers when used alone or in combination. The combination approach was most effective, suggesting that enzyme-based treatments could become useful additions to current fungal infection therapies.

Read More »

Five-Year Retrospective Analysis of Superficial Fungal Infections: Insights from Hospital Experience

mycolabadmin

This study examined fungal skin infections in over 3,900 patients at a Serbian military hospital over five years. Researchers found that common fungi like Trichophyton mentagrophytes and T. rubrum caused most infections, with patterns varying by season, patient gender, and body location. Men were more likely to have foot infections while women showed more diverse fungal types. The findings suggest doctors should use more precise identification methods like MALDI-TOF testing to prescribe better treatments and help prevent recurring infections.

Read More »

The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum

mycolabadmin

Researchers discovered that a protein called TrPtk2 helps dermatophytes resist terbinafine, a common antifungal medicine. They found that blocking this protein makes the fungus more susceptible to terbinafine. Additionally, they discovered that omeprazole, a stomach medication approved for human use, can be combined with terbinafine to make it more effective against resistant fungal infections.

Read More »
Scroll to Top